Replimune (REPL) Income from Continuing Operations (2017 - 2025)

Replimune's (REPL) quarterly Income from Continuing Operations came in at 70930000.0 in Q4 2025, down 6.92% year-on-year from 76202367.61 in Q4 2024, and up 13.59% quarter-over-quarter from 82083000.0 in Q3 2025.

Replimune (REPL) Income from Continuing Operations (2017 - 2025) Analysis & Trends

Replimune has disclosed Income from Continuing Operations across 9 years of filings, most recently posting 70930000.0 for Q4 2025.

  • Income from Continuing Operations for Q4 2025 came in at 70930000.0, down 6.92% year-over-year; the trailing twelve-month figure through Dec 2025 was 314333000.0 (down 37.72% YoY), and the FY2025 annual result was 247329000.0, down 14.61% from the prior year.
  • Income from Continuing Operations came in at 70930000.0 for Q4 2025 at Replimune, up from 82083000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 22090000.0 in Q1 2021 to a low of 87183000.0 in Q2 2025.
  • The 5-year median for Income from Continuing Operations is 50337500.0 (2023), against an average of 50879600.0.
  • Across the five-year window, Income from Continuing Operations advanced 11.64% in 2024 and plunged 62.13% in 2025, its largest moves.
  • Replimune's Income from Continuing Operations stood at 29611000.0 in 2021, then tumbled by 34.04% to 39690000.0 in 2022, then dropped by 28.8% to 51120000.0 in 2023, then slipped by 29.77% to 66340000.0 in 2024, then retreated by 6.92% to 70930000.0 in 2025.
  • The last three Income from Continuing Operations figures came in at 70930000.0 (Q4 2025), 82083000.0 (Q3 2025), and 87183000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -2.97 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -14.46 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -3.40 Mn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.71 Bn 91.71 Bn - -56.48 Mn
10 Replimune 780.01 Mn 510.88 Mn - -70.93 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -70.93 Mn
Sep 30, 2025 -82.08 Mn
Jun 30, 2025 -87.18 Mn
Mar 31, 2025 -74.14 Mn
Dec 31, 2024 -66.34 Mn
Sep 30, 2024 -53.06 Mn
Jun 30, 2024 -53.77 Mn
Mar 31, 2024 -55.08 Mn
Dec 31, 2023 -51.12 Mn
Sep 30, 2023 -60.04 Mn
Jun 30, 2023 -49.56 Mn
Mar 31, 2023 -49.24 Mn
Dec 31, 2022 -39.69 Mn
Sep 30, 2022 -43.10 Mn
Jun 30, 2022 -42.25 Mn
Mar 31, 2022 -31.86 Mn
Dec 31, 2021 -29.61 Mn
Sep 30, 2021 -29.17 Mn
Jun 30, 2021 -27.29 Mn
Mar 31, 2021 -22.09 Mn